Alphagan Ruling Would Limit Need For Patent Certifications
Executive Summary
ANDA applicants are not required to certify to patents other than those covering the compound or the method of use being pursued, a Los Angeles federal court ruling in Allergan's Alphagan patent litigation against Alcon states